Acumen Pharmaceuticals Inc. (ABOS) stock fell during after-market, despite any current update
Acumen Pharmaceuticals Inc. (NASDAQ: (ABOS) stock plunged by 2.43% at last close while ABOS stock price declines by 5.34% in the pre-market trading session even though the company has not provided any news regarding this downfall. Acumen is a clinical-stage pharmaceutical business established in Charlottesville, Virginia, with clinical activities in Carmel, Indiana. It is developing […]